Fujii Y - Search Results

1

PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and Paraganglioma.

Miyauchi M, Akashi T, Furukawa A, Uchida K, Tamura T, Ando N, Kirimura S, Shintaku H, Yamamoto K, Ito T, Miura K, Kayamori K, Ariizumi Y, Asakage T, Kudo A, Tanabe M, Fujii Y, Ishibashi H, Okubo K, Murakami M, Yamada T, Takemoto A, Bae Y, Eishi Y, Ohashi K. Miyauchi M, et al. Among authors: fujii y. Endocr Pathol. 2022 Dec;33(4):506-518. doi: 10.1007/s12022-022-09730-4. Epub 2022 Aug 27. Endocr Pathol. 2022. PMID: 36029394

2

Successful long-term disease-free survival following multimodal treatments in a patient with a repeatedly recurrent refractory adrenal cortical carcinoma.

Fujii Y, Kageyama Y, Kawakami S, Masuda H, Arisawa C, Akamatsu H, Akashi T, Kihara K. Fujii Y, et al. Int J Urol. 2003 Aug;10(8):445-8. doi: 10.1046/j.1442-2042.2003.00651.x. Int J Urol. 2003. PMID: 12887367 Free article.

3

Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.

Koga F, Kawakami S, Fujii Y, Saito K, Ohtsuka Y, Iwai A, Ando N, Takizawa T, Kageyama Y, Kihara K. Koga F, et al. Among authors: fujii y. Clin Cancer Res. 2003 Nov 15;9(15):5501-7. Clin Cancer Res. 2003. PMID: 14654529

4

Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancer.

Koga F, Kageyama Y, Kawakami S, Fujii Y, Hyochi N, Ando N, Takizawa T, Saito K, Iwai A, Masuda H, Kihara K. Koga F, et al. Among authors: fujii y. J Urol. 2004 Mar;171(3):1080-4. doi: 10.1097/01.ju.0000110541.62972.08. J Urol. 2004. PMID: 14767275

5

Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.

Ohtsuka Y, Kawakami S, Fujii Y, Koga F, Saito K, Ando N, Takizawa T, Kageyama Y, Kihara K. Ohtsuka Y, et al. Among authors: fujii y. BJU Int. 2006 Jun;97(6):1322-6. doi: 10.1111/j.1464-410X.2006.06158.x. BJU Int. 2006. PMID: 16686732

6

Significance of ERBB2 overexpression in therapeutic resistance and cancer-specific survival in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach.

Inoue M, Koga F, Yoshida S, Tamura T, Fujii Y, Ito E, Kihara K. Inoue M, et al. Among authors: fujii y. Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):303-11. doi: 10.1016/j.ijrobp.2014.05.043. Int J Radiat Oncol Biol Phys. 2014. PMID: 25304790

7

High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol.

Tanabe K, Yoshida S, Koga F, Inoue M, Kobayashi S, Ishioka J, Tamura T, Sugawara E, Saito K, Akashi T, Fujii Y, Kihara K. Tanabe K, et al. Among authors: fujii y. Clin Genitourin Cancer. 2015 Aug;13(4):e243-e251. doi: 10.1016/j.clgc.2015.03.002. Epub 2015 Mar 27. Clin Genitourin Cancer. 2015. PMID: 25936588

8

A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma.

Murakami M, Yoshimoto T, Minami I, Bouchi R, Tsuchiya K, Hashimoto K, Izumiyama H, Fujii Y, Endo T, Akashi T, Nishimoto K, Mukai K, Kihara K, Ogawa Y. Murakami M, et al. Among authors: fujii y. Endocr Pathol. 2015 Dec;26(4):328-33. doi: 10.1007/s12022-015-9400-9. Endocr Pathol. 2015. PMID: 26481629

9

Molecular characteristics of the KCNJ5 mutated aldosterone-producing adenomas.

Murakami M, Yoshimoto T, Nakabayashi K, Nakano Y, Fukaishi T, Tsuchiya K, Minami I, Bouchi R, Okamura K, Fujii Y, Hashimoto K, Hata KI, Kihara K, Ogawa Y. Murakami M, et al. Among authors: fujii y. Endocr Relat Cancer. 2017 Oct;24(10):531-541. doi: 10.1530/ERC-17-0117. Epub 2017 Jul 26. Endocr Relat Cancer. 2017. PMID: 28747387

10

Neuroblastic tumors in young adults as a sequela of malignant neuroblastoma: report of two cases.

Adachi T, Yokoyama M, Fujii Y, Kinowaki Y, Kirimura S, Kubota K, Saida Y, Tateishi U. Adachi T, et al. Among authors: fujii y. Abdom Radiol (NY). 2018 Jul;43(7):1531-1534. doi: 10.1007/s00261-018-1586-0. Abdom Radiol (NY). 2018. PMID: 29619527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,435 results

Search Page